Sono-Tek Reports Increased Sales and Strong Backlog for First Quarter Fiscal 2022 and Provides Second Quarter Sales Guidance
Sono-Tek Corporation (SOTK) reported Q1 FY2022 sales of $3.64M, up 6% year-over-year, driven by demand in the semiconductor and electronic diagnostic markets. Gross profit rose 17% to $1.82M with a gross margin of 50%. Operating income increased 86% to $343K, while net income rose 56% to $261K, excluding $1M from PPP forgiveness. Backlog increased 14% to $4.38M. The company projects double-digit sales growth in Q2 and its highest annual sales in history for FY2022.
- Q1 sales up 6% to $3.64M, driven by strong semiconductor demand.
- Gross profit increased 17% to $1.82M, with a gross margin of 50%.
- Operating income rose 86% to $343K, indicating improved financial health.
- Backlog increased by 14% to $4.38M, suggesting strong future sales potential.
- Projected double-digit sales growth for Q2 FY2022.
- Sales in integrated coatings systems decreased due to a lack of large orders compared to Q1 FY2021.
Q1 Sales of
MILTON, N.Y., July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its first quarter period of fiscal year 2022, ended May 31, 2021.
First Quarter FY2022 Financial Highlights:
(Compared with prior-year period unless otherwise noted)
- Net Sales were
$3,644,000 , an increase of6% , primarily driven by strength in the semiconductor and electronic diagnostic coating markets. - Gross Profit increased
17% to$1,824,000 , and Gross Margin expanded 450 basis points to50.0% , primarily due to product mix and lower warranty and installation costs. - Operating Income increased
86% to$343,000. - Net Income increased
56% to$261,000 , excluding the benefit from Paycheck Protection Program Loan, (“PPP”) forgiveness of$1.0 million . - Stockholders’ Equity increased
$1,288,000 t o$12,239,000 reflecting the current period’s net income. - As of May 31, 2021, the Company has no outstanding debt.
- Backlog at May 31, 2021 grew to
$4,380,000 , up$529,000 or13.7% , from fiscal yearend at February 28, 2021. - Sales Growth Guidance for the second quarter of FY2022, ending August 31, 2021, is for a double digit increase over the second quarter of last year.
- Sono-Tek continues to project its highest ever annual sales for fiscal year 2022, ending February 28, 2022.
Dr. Christopher L. Coccio, Chairman and CEO, commented, “Sono-Tek’s sales increased
“Our fiscal second quarter, ending August 31, 2021, has had a fine start, and we expect to report a double digit increase over the second quarter of last year. We continue to project the highest annual sales in corporate history for fiscal year 2022, ending February 28, 2022. These gains stem from the strategic shift in our business model that was initiated several years ago, that expanded our product line to provide higher value, complete machine solutions and larger subsystems to original equipment manufacturers (“OEMs”). These product advancements are supported by a high level of application engineering expertise from our specialized staff. Combined with customer requirements, these advancements are proven out in our global network of process development labs, which we believe give Sono-Tek a competitive advantage in meeting the growing global demand for ultrasonic coating systems,” concluded Dr. Coccio.
First Quarter Fiscal 2022 Results
Three Months Ended May 31, | Change | |||
2021 | 2020 | $ | % | |
Net Sales | $ 3,644,000 | $ 3,429,000 | 215,000 | |
Gross Profit | 1,824,000 | 1,561,000 | 263,000 | |
Gross Margin | ||||
Operating Income | $ 343,000 | $ 184,000 | 159,000 | |
Operating Margin | ||||
Net Income | $ 1,247,000 | $ 168,000 | 1,099,000 | |
Net Margin | ||||
Basic Earnings Per Share | ||||
Diluted Earnings Per Share | ||||
Weighted Average Shares -Basic | 15,494,000 | 15,398,000 | ||
Weighted Average Shares - Diluted | 15,664,000 | 15,437,000 |
First Quarter FY2022 Financial Overview
Fiscal first quarter net sales were
In the first quarter of fiscal 2022, approximately
Backlog at May 31, 2021 grew to
Gross profit margin increased 450 basis points to
Operating income increased to
Net income for the first quarter was
Balance Sheet and Cash Flow Overview
Cash and cash equivalents and short-term investments at quarter-end were
Capital expenditures in the first quarter totaled
At May 31, 2021, the Company had no debt on its balance sheet. During the first quarter, the Company recorded a gain on the forgiveness of its PPP Loan, awarded under the CARES Act, and accrued interest in the amount of
About Sono-Tek
Sono-Tek Corporation is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.
The Company’s solutions are environmentally-friendly, efficient and highly reliable and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
Sono-Tek’s growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop microscopic coating technologies that enable better outcomes for its customers’ products and processes.
For further information, visit www.sono-tek.com.
Safe Harbor Statement
We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, news releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; the duration and scope of the COVID-19 pandemic; the extent and duration of the pandemic’s adverse effect on economic and social activity, consumer confidence, discretionary spending and preferences, labor and healthcare costs, and unemployment rates, any of which may reduce demand for some of our products and impair the ability of those with whom we do business to satisfy their obligations to us; our ability to sell and provide our services and products, including as a result of continued pandemic related travel restrictions, mandatory business closures, and stay-at home or similar orders; any temporary reduction in our workforce, closures of our offices and facilities and our ability to adequately staff and maintain our operations resulting from the pandemic; the ability of our customers and suppliers to continue their operations as result of the pandemic, which could result in terminations of contracts, losses of revenue; the recovery of the Electronics/ Microelectronics and Medical markets following COVID-19 related slowdowns; and further adverse effects to our supply chain; maintenance of increased order backlog, including effects of any COVID-19 related cancellations; the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; maintenance of increased order backlog; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the medical and alternative energy markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within forecasted range of sales guidance. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.
For more information, contact:
Stephen J. Bagley
Chief Financial Officer
Sono-Tek Corporation
info@sono-tek.com
Investor Relations:
Stephanie Prince
PCG Advisory
(646) 863-6341
sprince@pcgadvisory.com
FINANCIAL TABLES FOLLOW
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
May 31, 2021 | February 28, | |||||||
(Unaudited) | 2021 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 5,793,647 | $ | 4,084,078 | ||||
Marketable securities | 3,490,358 | 4,563,470 | ||||||
Accounts receivable (less allowance of | 1,168,571 | 1,757,802 | ||||||
Inventories, net | 2,612,220 | 2,611,106 | ||||||
Prepaid expenses and other current assets | 108,456 | 151,316 | ||||||
Total current assets | 13,173,252 | 13,167,772 | ||||||
Land | 250,000 | 250,000 | ||||||
Buildings, net | 1,550,547 | 1,575,135 | ||||||
Equipment, furnishings and building improvements, net | 1,082,634 | 1,075,190 | ||||||
Intangible assets, net | 90,596 | 95,456 | ||||||
Deferred tax asset | 236,120 | 259,838 | ||||||
TOTAL ASSETS | $ | 16,383,149 | $ | 16,423,391 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 1,188,103 | $ | 1,294,483 | ||||
Accrued expenses | 1,388,606 | 1,750,916 | ||||||
Customer deposits | 1,247,071 | 1,166,541 | ||||||
Income taxes payable | 137,287 | 53,567 | ||||||
Total current liabilities | 3,961,067 | 4,265,507 | ||||||
Deferred tax liability | 183,011 | 205,562 | ||||||
Long term debt, less current maturities | - | 1,001,640 | ||||||
Total liabilities | 4,144,078 | 5,472,709 | ||||||
Stockholders’ Equity | ||||||||
Common stock, $.01 par value; 25,000,000 shares authorized, 15,502,557 and 15,452,656 shares issued and outstanding, respectively | 155,026 | 154,527 | ||||||
Additional paid-in capital | 9,086,132 | 9,064,994 | ||||||
Accumulated earnings | 2,997,913 | 1,731,161 | ||||||
Total stockholders’ equity | 12,239,071 | 10,950,682 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 16,383,149 | $ | 16,423,391 |
See notes to unaudited condensed consolidated financial statements.
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended May 31, | ||||||||
2021 | 2020 | |||||||
Net Sales | $ | 3,644,468 | $ | 3,428,544 | ||||
Cost of Goods Sold | 1,820,303 | 1,867,811 | ||||||
Gross Profit | 1,824,165 | 1,560,733 | ||||||
Operating Expenses | ||||||||
Research and product development costs | 413,816 | 411,424 | ||||||
Marketing and selling expenses | 764,642 | 706,717 | ||||||
General and administrative costs | 302,799 | 258,402 | ||||||
Total Operating Expenses | 1,481,257 | 1,376,543 | ||||||
Operating Income | 342,908 | 184,190 | ||||||
Interest Expense | - | (8,417 | ) | |||||
Interest and Dividend Income | 3,360 | 22,646 | ||||||
Other Income | - | 11,435 | ||||||
Paycheck Protection Program Loan Forgiveness | 1,005,372 | - | ||||||
Income Before Income Taxes | 1,351,640 | 209,854 | ||||||
Income Tax Expense | 84,888 | 41,926 | ||||||
Net Income | $ | 1,266,752 | $ | 167,928 | ||||
Basic Earnings Per Share | $ | 0.08 | $ | 0.01 | ||||
Diluted Earnings Per Share | $ | 0.08 | $ | 0.01 | ||||
Weighted Average Shares - Basic | 15,494,421 | 15,397,779 | ||||||
Weighted Average Shares - Diluted | 15,663,772 | 15,436,758 |
See notes to unaudited condensed consolidated financial statements.
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended May 31, | ||||||||
2021 | 2020 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net Income | $ | 1,266,752 | $ | 167,928 | ||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 107,553 | 109,878 | ||||||
Stock based compensation expense | 21,637 | 8,097 | ||||||
Inventory reserve | 31,000 | 18,000 | ||||||
Paycheck Protection Program Loan Forgiveness | (1,005,372) | _ | ||||||
Deferred tax expense | 1,167 | - | ||||||
Decrease (Increase) in: | ||||||||
Accounts receivable | 589,231 | (411,916 | ) | |||||
Inventories | (32,114 | ) | (148,331 | ) | ||||
Prepaid expenses and other current assets | 42,860 | 7,110 | ||||||
(Decrease) Increase in: | ||||||||
Accounts payable and accrued expenses | (464,960) | 134,554 | ||||||
Customer deposits | 80,530 | (322,996) | ||||||
Income taxes payable | 83,721 | 41,927 | ||||||
Net Cash Provided By (Used in) Operating Activities | 722,005 | (395,749) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchase of equipment, furnishings and leasehold improvements | (85,548 | ) | (152,402 | ) | ||||
Sale of marketable securities | 1,073,112 | 310,786 | ||||||
Net Cash Provided By Investing Activities | 987,564 | 158,384 | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from note payable - bank | - | 1,001,640 | ||||||
Repayment of long-term debt | - | (41,879 | ) | |||||
Net Cash Provided By Financing Activities | - | 959,761 | ||||||
NET INCREASE IN CASH AND CASH EQUIVALENTS | 1,709,569 | 722,396 | ||||||
CASH AND CASH EQUIVALENTS | ||||||||
Beginning of period | 4,084,078 | 3,659,551 | ||||||
End of period | $ | 5,793,647 | $ | 4,381,947 | ||||
SUPPLEMENTAL CASH FLOW DISCLOSURE: | ||||||||
Interest paid | $ | - | $ | 7,210 | ||||
Taxes Paid | $ | — | $ | — |
See notes to unaudited condensed consolidated financial statements.
SONO-TEK CORPORATION
ADDITIONAL INFORMATION – MARKET AND PRODUCT SALES
(Unaudited)
Product Sales:
Three Months Ended May 31, | Change | |||||||||||||||||||||||
2021 | % of total | 2020 | % of total | $ | % | |||||||||||||||||||
Fluxing Systems | $ | 358,000 | $ | 344,000 | 14,000 | |||||||||||||||||||
Integrated Coating Systems | 155,000 | 1,176,000 | (1,021,000 | ) | ( | |||||||||||||||||||
Multi-Axis Coating Systems | 2,079,000 | 913,000 | 1,166,000 | |||||||||||||||||||||
OEM Systems | 326,000 | 422,000 | (96,000) | ( | ) | |||||||||||||||||||
Other | 726,000 | 574,000 | 152,000 | |||||||||||||||||||||
TOTAL | $ | 3,644,000 | $ | 3,429,000 | $ | 215,000 |
Market Sales:
Three Months Ended May 31, | Change | |||||||||||||||||||||||
2021 | % of total | 2020 | % of total | $ | % | |||||||||||||||||||
Electronics/Microelectronics | $ | 2,258,000 | $ | 2,240,000 | 18,000 | |||||||||||||||||||
Medical | 717,000 | 692,000 | 25,000 | |||||||||||||||||||||
Alternative Energy | 432,000 | 395,000 | 37,000 | |||||||||||||||||||||
Emerging R&D and Other | 166,000 | 37,000 | 129,000 | |||||||||||||||||||||
Industrial | 71,000 | 65,000 | 6,000 | |||||||||||||||||||||
TOTAL | $ | 3,644,000 | $ | 3,429,000 | $ | 215,000 |
FAQ
What were Sono-Tek's sales for Q1 FY2022?
How much did Sono-Tek's net income increase in Q1 FY2022?
What is Sono-Tek’s backlog figure as of May 31, 2021?
What is Sono-Tek's sales growth guidance for Q2 FY2022?